ID

14828

Beschreibung

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane; ODM derived from: https://clinicaltrials.gov/show/NCT00036270

Link

https://clinicaltrials.gov/show/NCT00036270

Stichworte

  1. 01.05.16 01.05.16 -
Hochgeladen am

1. Mai 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Neoplasms NCT00036270

Eligibility Breast Neoplasms NCT00036270

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically/cytologically confirmed adenocarcinoma of the breast, followed by adequate surgical resection and/or radiotherapy, and/or adjuvant chemotherapy, if indicated.
Beschreibung

ID.1

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C0679557
UMLS CUI [2]
C0728940
UMLS CUI [3]
C1522449
UMLS CUI [4]
C0392920
stage t1-3 n0-2 mo, any tnm stage bc for whom adjuvant hormonal therapy is being considered.
Beschreibung

ID.2

Datentyp

boolean

Alias
UMLS CUI [1]
C1515169
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
those patients not deemed to have had potentially curative primary surgical treatment or one of the following criteria:
Beschreibung

ID.3

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0038894
UMLS CUI [1,2]
C1276305
inflammatory breast cancer
Beschreibung

ID.4

Datentyp

boolean

Alias
UMLS CUI [1]
C0278601
histologically positive supraclavicular nodes
Beschreibung

ID.5

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0229730
UMLS CUI [1,2]
C0019638
ulceration/infiltration of local skin metastasis
Beschreibung

ID.6

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C1123023
UMLS CUI [1,3]
C0041582
UMLS CUI [1,4]
C0332448
neoadjuvant chemotherapy
Beschreibung

ID.7

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600558
UMLS CUI [1,2]
C3665472
ductal carcinoma in situ (dcis) or lobular carcinoma in situ (lcis) without invasion
Beschreibung

ID.8

Datentyp

boolean

Alias
UMLS CUI [1]
C0007124
UMLS CUI [2]
C0279563
er and pr negative primary tumor or er/pr unknown status.
Beschreibung

ID.9

Datentyp

boolean

Alias
UMLS CUI [1]
C2919271
UMLS CUI [2]
C2919590

Ähnliche Modelle

Eligibility Breast Neoplasms NCT00036270

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically/cytologically confirmed adenocarcinoma of the breast, followed by adequate surgical resection and/or radiotherapy, and/or adjuvant chemotherapy, if indicated.
boolean
C0858252 (UMLS CUI [1,1])
C0679557 (UMLS CUI [1,2])
C0728940 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
ID.2
Item
stage t1-3 n0-2 mo, any tnm stage bc for whom adjuvant hormonal therapy is being considered.
boolean
C1515169 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.3
Item
those patients not deemed to have had potentially curative primary surgical treatment or one of the following criteria:
boolean
C0038894 (UMLS CUI [1,1])
C1276305 (UMLS CUI [1,2])
ID.4
Item
inflammatory breast cancer
boolean
C0278601 (UMLS CUI [1])
ID.5
Item
histologically positive supraclavicular nodes
boolean
C0229730 (UMLS CUI [1,1])
C0019638 (UMLS CUI [1,2])
ID.6
Item
ulceration/infiltration of local skin metastasis
boolean
C0027627 (UMLS CUI [1,1])
C1123023 (UMLS CUI [1,2])
C0041582 (UMLS CUI [1,3])
C0332448 (UMLS CUI [1,4])
ID.7
Item
neoadjuvant chemotherapy
boolean
C0600558 (UMLS CUI [1,1])
C3665472 (UMLS CUI [1,2])
ID.8
Item
ductal carcinoma in situ (dcis) or lobular carcinoma in situ (lcis) without invasion
boolean
C0007124 (UMLS CUI [1])
C0279563 (UMLS CUI [2])
ID.9
Item
er and pr negative primary tumor or er/pr unknown status.
boolean
C2919271 (UMLS CUI [1])
C2919590 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video